L
Lorenz Trümper
Researcher at University of Göttingen
Publications - 276
Citations - 22696
Lorenz Trümper is an academic researcher from University of Göttingen. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 53, co-authored 260 publications receiving 19534 citations. Previous affiliations of Lorenz Trümper include Deutsche Forschungsgemeinschaft & University of Cologne.
Papers
More filters
Journal ArticleDOI
A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma.
Marion Hoffmann,Markus A. Schirmer,Mladen V. Tzvetkov,Markus Kreuz,Marita Ziepert,Leszek Wojnowski,Dieter Kube,Michael Pfreundschuh,Lorenz Trümper,Markus Loeffler,Jürgen Brockmöller +10 more
TL;DR: CYBA 640A>G was shown to be a functional polymorphism with possible consequences for patients receiving CHO(E)P chemotherapy and might have further implications for other ROS-mediated modalities.
Journal ArticleDOI
Oral health status in adult patients with newly diagnosed acute leukemia
TL;DR: The high prevalence of oral diseases supports the demand of an early and consequent dental treatment of leukemia patients, especially considering subsequent therapy.
Journal ArticleDOI
Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes.
TL;DR: A phase II trial with low-dose Ara-C and 13-CRA in 14 patients with MDS, six of whom had refractory anemia with excess of blasts, seven had RAEB in transformation (RAEBt) and one chronic myelomonocytic leukemia (CMML).
Journal ArticleDOI
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy,Chip Stewart,Andrew Dunford,Jaegil Kim,Atanas Kamburov,Robert A. Redd,Michael S. Lawrence,Michael S. Lawrence,Margaretha G.M. Roemer,Amy Li,Marita Ziepert,Annette M. Staiger,Annette M. Staiger,Jeremiah Wala,Matthew D. Ducar,Ignaty Leshchiner,Ester Rheinbay,Amaro Taylor-Weiner,Caroline A. Coughlin,Julian M. Hess,Chandra Sekhar Pedamallu,Dimitri Livitz,Daniel Rosebrock,Mara Rosenberg,Adam Tracy,Heike Horn,Paul Van Hummelen,Andrew L. Feldman,Brian K. Link,Anne J. Novak,James R. Cerhan,Thomas M. Habermann,Reiner Siebert,Andreas Rosenwald,Aaron R. Thorner,Matthew Meyerson,Matthew Meyerson,Todd R. Golub,Todd R. Golub,Rameen Beroukhim,Rameen Beroukhim,Gerald Wulf,German Ott,Scott J. Rodig,Scott J. Rodig,Stefano Monti,Donna Neuberg,Markus Loeffler,Michael Pfreundschuh,Lorenz Trümper,Gad Getz,Gad Getz,Margaret A. Shipp +52 more
TL;DR: In the version of this article originally published, an asterisk was omitted from Fig. 1a and a “NOTCH2” label was erroneously included in Fig. 4a.
Journal ArticleDOI
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
Dieter Kube,Thanh-Duc Hua,M. Klöss,Bettina Kulle,Bettina Kulle,Jürgen Brockmöller,Leszek Wojnowski,Markus Löffler,Michael Pfreundschuh,Lorenz Trümper +9 more
TL;DR: This study established the IL-10 genotypes in patients from the NHL-B1/ B2 studies from the German High-Grade Non-Hodgkin's Lymphoma Study Group and found no difference in OS or event-free survival between patients with IL- 10–1087AA and the other genotypes.